NUS researchers use AI to successfully treat metastatic cancer patient

A translational research team led by Prof Dean Ho, Director of the Singapore Institute for Neurotechnology at NUS, has harnessed CURATE.AI, a powerful artificial intelligence (AI) platform to successfully treat a patient with advanced cancer, completely halting disease progression. This new development represents a big step forward in personalised medicine.